Facts and figures
2019 has been influenced by additional capital allowance and value adjustments as part of a year of transformation. The extension of the syndicated loan and the sale of the Pharmalys companies were two important measures. In the future, HOCHDORF will focus on the Baby Care and Dairy Ingredients divisions.
The HOCHDORF Group
HOCHDORF was founded in 1895 and develops, produces and sells high-quality infant formula, food for special medical purposes and milk derivatives at its three sites in Switzerland. HOCHDORF infant formula own brands are marketed via HOCHDORF Swiss Nutrition Ltd and Bimbosan AG. HOCHDORF also runs an oil mill in Germany. HOCHDORF is one of Switzerland's leading food companies and employed over 600 people globally as of 31.12.2019. HOCHDORF’s products make an important contribution towards the health and well-being of infants and senior citizens alike. The products are sold to the food industry, wholesalers and retailers and to end users in over 70 countries.
Our 2025 strategy
HOCHDORF is a medium-sized, independent company that operates both in Switzerland and on the international market in the strategic areas of Baby Care and Dairy Ingredients. We stand out on the market as a «BEST PARTNER» by combining traditional Swiss values such as «reliability», «quality» and «precision» with comprehensive customer service, innovation, an understanding of the international market and professional pragmatism – we get things done!
In the future, HOCHDORF will focus more consistently on premium and niche markets and use high-quality infant formula, foods for special medical purposes and milk derivatives to continue to grow both turnover and revenue in Switzerland and on the international markets. Our highly-qualified and committed employees and a mutually trusting relationship with strong partners for raw ingredients, innovative development and marketing are all crucial for our future success. The marketing of our own «Bimbosan» brand in selected international markets has a key role in our strategy.
Key figures in the annual report
|Processed milk and whey in tonnes||677,845||661,017||650,017||741,769||761,240|
|Products sold, in tonnes||162,093||154,609||190,499||237,054||242,821|
|Total assets (in TCHF)||455,572||575,231||582,270||425,474||340,396|
|Cash flow from operating activities (in TCHF)||–15,430||–81,279||6,019||24,227||19,011|
|Market capitalisation (in TCHF)||146,296||146,346||410,700||444,417||242,044|
|Share price as at 31.12. in CHF||83.20||102.00||286.25||309.75||168.70|
|Earnings per share in CHF||–164.56||2.02||18.43||14.12||11.73|
|Staffing levels at 31.12.||618||694||695||633||625|